SCTbio a.s. – Trademark Portfolio

Entity Type: 98

SCTbio a.s. holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 2 filings in this category. The portfolio also extends into Class 39 (Transportation & Storage) across 3 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include SCTBIO and SCT BIO.

Jankovcova 1518/2

CZ-170 00 Prague 7

2 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

SCT BIO
SCT BIO
Registered 2022
SCTBIO
SCTBIO
Registered 2022

Trademark Classifications

SCTbio a.s.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

42
Computer & Scientific (2 filings)

Scientific and technological services; industrial analysis and research services

39
Transportation & Storage (2 filings)

Transport; packaging and storage of goods; travel arrangement

40
Treatment & Processing (2 filings)

Treatment of materials

Frequently Asked Questions

How many trademarks does SCTbio a.s. have?

SCTbio a.s. has 2 U.S. trademarks filed with the USPTO. Of these, 2 registered.

What trademark classes does SCTbio a.s. file in?

SCTbio a.s. files trademarks across 3 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 39 (Transportation & Storage), Class 40 (Treatment & Processing). Class 42 covers scientific and technological services; industrial analysis and research services.

What are SCTbio a.s.'s most well-known trademarks?

SCTbio a.s.'s registered trademark portfolio includes well-known marks such as SCTBIO and SCT BIO. These are among 2 currently registered trademarks in the portfolio.

What is SCTbio a.s.'s trademark registration success rate?

SCTbio a.s. has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.